Gossamer Bio
Tracked across 2 events · 40 articles · First seen Apr 01, 2026 · Last active Jun 17, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Gossamer Bio is subject to a class action lawsuit because its Phase 3 PROSERA study allegedly failed to meet its primary endpoint due to patient demographics at Latin American sites, leading to misleading positive statements.
May 18, 2026 · 20 articles
Regulatory
Impact: Gossamer Bio is facing a class action lawsuit due to allegations that its Phase 3 PROSERA study failed to meet its primary endpoint, leading to misleading positive statements.
May 18, 2026 · 20 articles
68
Gossamer Bio failed to meet endpointMultiple Class Action...
ERGEN INTELLIGENCE
Track Gossamer Bio live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard